Expression of T follicular helper lymphocytes with different subsets and analysis of serum IL-6, IL-17, TGF- β and MMP-3 contents in patients with rheumatoid arthritis.
CONCLUSIONS: Tfh2 and Tfh17 are expected to be new targets for immunotherapy in RA patients.
PMID: 30657547 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Allergy & Immunology | Arthritis | Drugs & Pharmacology | Immunotherapy | Men | Rheumatoid Arthritis | Rheumatology